Para profundizar

Artículos sobre SCN2A

Una selección de artículos, notas y publicaciones externas para seguir aprendiendo sobre SCN2A.

academic.oup.com

academic.oup.com

Distinctive In Vitro Phenotypes in iPSC-Derived Neurons From Patients With Gain- and Loss-of-Function SCN2A Developmental and Epileptic Encephalopathy

SCN2A encodes NaV1.2, an excitatory neuron voltage-gated sodium channel and a major monogenic cause of neurodevelopmental disorders, including developmental and epileptic encephalopathies (DEE) and autism. Clinical presentation and ...

pmc.ncbi.nlm.nih.gov

academic.oup.com

academic.oup.com

prime editing gene correction of the developmental epileptic and encephalopathy causing scn2a-l1342p variant in ipsc-derived neurons and organoids

aesnet.org

Pathogenic SCN2A variants cause early-stage dysfunction in patient-derived neurons

Pathogenic heterozygous variants in SCN2A, which encodes the neuronal sodium channel NaV1.2, cause different types of epilepsy or intellectual disability (ID)/autism without seizures. Previous studies using mouse models or heterologous systems ...

pmc.ncbi.nlm.nih.gov

Functional correlates of clinical phenotype and severity in recurrent SCN2A variants

In SCN2A-related disorders, there is an urgent demand to establish efficient methods for determining the gain- (GoF) or loss-of-function (LoF) character of variants, to identify suitable candidates for precision therapies. Here we classify clinical ...

pmc.ncbi.nlm.nih.gov

Epilepsy-associated SCN2A (NaV1.2) variants exhibit diverse and complex functional properties

Hundreds of genetic variants in the voltage-gated sodium channel NaV1.2 are associated with a spectrum of neurodevelopmental disorders with or without epilepsy. High throughput automated patch-clamp recording of several variants revealed more ...

pmc.ncbi.nlm.nih.gov

Mechanisms of SCN2A loss of function do not predict presence or phenotype of epilepsy

SCN2A loss‐of‐function (LoF) variants are associated with epilepsy (onset age ≥ 3 months), intellectual disability (ID), and autism spectrum disorder (ASD). Despite numerous identified variants and the description of phenotypic subgroups, ...

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov

SCN2A channelopathies in the autism spectrum of neuropsychiatric disorders: a role for pluripotent stem cells?

Efforts to identify the causes of autism spectrum disorders have highlighted the importance of both genetics and environment, but the lack of human models for many of these disorders limits researchers’ attempts to understand the mechanisms of ...

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov

onlinelibrary.wiley.com

onlinelibrary.wiley.com

Epilepsy-Associated SCN2A-L1342P Mutation Drives Network Hyperexcitability and Widespread Transcriptomic Changes in Human Cortical Organoids

SCN2A pathogenic mutations, such as the recurrent heterozygous Nav1.2-L1342P, are monogenic causes of epilepsy. In this human-induced pluripotent stem cell model system, we aim to investigate the molecular and cellular mechanisms underlying the ...

pmc.ncbi.nlm.nih.gov

onlinelibrary.wiley.com

onlinelibrary.wiley.com

nature.com

nature.com